John Wiley & Sons Stock Earnings Reports

Wiley reported a seasonally small Q1 that was largely in line with management expectations. Key positives: strong momentum in AI licensing (Q1 AI revenue $29M, including a landmark ~$20M project that for the first time included partner publisher content), continued open access growth (double-digit, with Advanced Science revenue up ~50% YoY and a record month for OA submissions in July), accelerating research submissions (+25%) and output (+13%), and progress migrating journals to a new AI-enabled publishing platform (1,000 journals live). Management reaffirmed fiscal 2026 guidance: low- to mid-single-digit revenue growth, adjusted EBITDA margin target 25.5%–26.5%, adjusted EPS $3.90–$4.35, and free cash flow ~ $200M. Cost savings are expected to ramp in Q2; corporate expenses included a one-time ~$4M strategic consulting charge in Q1 that management expects not to recur. Capital allocation: 32nd consecutive dividend increase, a $250M share repurchase authorization (up 25%), $14M of buybacks executed in the quarter, and continued debt reduction (net debt/EBITDA ~1.9). Management highlighted the strategic priority of expanding into corporate R&D and inference/subscription AI models (pilots with pharma and other verticals) while preserving content sovereignty for publishing partners through the Wiley Nexus. Risks/notes: Q1 comparables and timing items (including lapped renewal benefits) created noise; professional publishing and retail channels showed softness; AI revenue can be lumpy quarter-to-quarter.